Liminal Biosciences Inc (DELISTED) (LMNL:DL)

8.50 USD  |  NASDAQ  |  Sep 25, 15:59
More

Liminal Biosciences Non-Current Deferred Revenue (Quarterly)

Non-Current Deferred Revenue (Quarterly) Chart

View Non-Current Deferred Revenue (Quarterly) for LMNL:DL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Deferred Revenue (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Deferred Revenue (Quarterly) Benchmarks

View Non-Current Deferred Revenue (Quarterly) Benchmarks
Start Trial
Grace Therapeutics, Inc. --
Aurinia Pharmaceuticals, Inc. Upgrade
Edesa Biotech, Inc. --
Lexaria Bioscience Corp. --
Xenon Pharmaceuticals, Inc. --